The Effects of Simulated Competition on Repeated-sprint Cycling Performance
The Effect of Simulated Competition on Repeated-sprint Cycling Performance and on Measures of Physiological and Psychological Stress.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- regular strength/sprint training (at least 2 sessions per week)
Exclusion Criteria:
- Injured or a contraindicative medical condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Simulated competition
During the experimental condition, the participants will be competing for a reward, will be given verbal encouragement, and will receive performance feedback.
|
During a competition, athletes will typically compete for a reward, against opponents and in the presence of others.
This will be replicated in the laboratory.
|
|
NO_INTERVENTION: Control
During the control condition, the participants will be asked to sprint without verbal encouragement or any performance feedback.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sprint Power Output
Time Frame: From baseline to completion, ~42 days
|
The Lode Excalibur Sport cycle ergometer records power output at 5Hz.
Peak power output will be defined as the highest power output recorded.
Mean power output will be calculated as the average power output over the 27 s sprint.
Comparisons will be made between conditions.
|
From baseline to completion, ~42 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart-rate Variability
Time Frame: From baseline to completion, ~42 days
|
Heart-rate variability provides a measure of physiological stress.
Recordings will be taken at rest, after the warm-up, and following the sprints.
Comparisons will be made between conditions.
|
From baseline to completion, ~42 days
|
|
Salivary Concentration of Alpha Amylase
Time Frame: From baseline to completion, ~42 days
|
Alpha amylase is a digestive enzyme found in saliva.
Alpha amylase also provides a measure of physiological stress.
Recordings will be taken at rest, after the warm-up, and following the sprints.
Comparisons will be made between conditions.
|
From baseline to completion, ~42 days
|
|
20 cm Visual Analogue Scale to Assess Anxiety
Time Frame: From baseline to completion, ~42 days
|
The scale will range from not at all anxious to very anxious.
Participants will be asked to indicate how anxious they feel by place a clear mark on the scale.
Measurements will be taken at rest, after the warm-up, and following the sprints.
Comparisons will be made between conditions.
|
From baseline to completion, ~42 days
|
|
20 cm Visual Analogue Scale to Assess Self-efficacy
Time Frame: From baseline to completion, ~42 days
|
The scale will range from cannot do it at all to highly certain.
Participants will be asked about their confidence in their ability to improve on their baseline sprint performance.
Measurements will be taken just prior to each sprint.
Comparison to baseline.
|
From baseline to completion, ~42 days
|
|
Sport Anxiety Scale-2 - a questionnaire to assess cognitive and somatic anxiety.
Time Frame: Baseline
|
Measured once.
Correlation will performance.
The response for each question carries a score of between 1 and 4. A higher number is reflective of a greater level of anxiety.
|
Baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- StMarysUC6
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.